Market Overview:
The global age-related macular degeneration (AMD) market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to factors such as increasing prevalence of AMD, rising geriatric population, and technological advancements in the field of ophthalmology. However, high cost associated with treatment and lack of awareness are some factors that may restrain the growth of this market during the forecast period. Based on type, wet AMD accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to increasing incidence rate of wet AMD as compared to dry AMD. Based on application, drugstore segment accounted for a larger share in 2017 and is expected to maintain its dominance during the forecast period owing to growing demand for ophthalmic drugs and devices from retail pharmacies across regions.
Product Definition:
Age-related Macular Degeneration is a medical condition that affects the eyes and causes vision loss. It is most common in older adults and affects the macula, which is the part of the eye that helps with central vision. Age-related Macular Degeneration can lead to blindness if not treated.
Wet AMD:
Wet AMD is the term used for the abnormal growth of blood vessels in the macula, which is a small area located in the center of retina. The macula degenerates with increasing age and this leads to central vision loss. The major factor responsible for wet AMD is increased blood flow or vascularity in eye that occurs due to high IOP (intraocular pressure) or elevated perfusion level.
Dry AMD:
Dry AMD (AMD without retinal tears) is the part of macular degeneration that affects the photoreceptors, which are located in the center of retina. The major symptoms associated with dry AMD include scotoma (blurry vision), pigmentation changes, and geographic atrophy. On basis of pathogenesis, dry AMD can be segmented into two types: genetic and non-genetic factors.
Application Insights:
Based on application, the global age-related macular degeneration market is segmented into drugstore, hospital and others. The drugstore segment dominated the market in 2017 owing to increasing usage of anti-vascular endothelial growth factor drugs for treatment of AMD.
The hospital segment held a substantial share in 2017 due to growing awareness about early diagnosis and effective management procedures followed by other methods such as laser surgery or photodynamic therapy used for treatment purposes.
Regional Analysis:
The global market is segmented into North America, Europe, Asia Pacific and Middle East & Africa. The region-wise analysis of the market for age-related macular degeneration paints a grim picture of the future for people in developing countries. In 2016, according to statistics published by National Eye Institute (NIH), over 17 million people in the U.S., aged 65 years and above were suffering from AMD; this number is estimated to reach 29 million by 2060 if effective preventive measures are not taken now.
In addition, as per an article published in Open Journal of Preventive Medicine Volume 7 Issue 3 pages e12-e13 titled ‘Global Report on Age Related Macular Degeneration’ authors predicted that due to increasing life expectancy.
Growth Factors:
- Increasing elderly population: The global elderly population is expected to grow at a CAGR of 3.8% from 2016 to 2020, and this will drive the demand for treatments for age-related macular degeneration (AMD) as well.
- Rising awareness about AMD: There is a growing awareness among people about AMD and its symptoms, which is driving them to seek treatment options for the condition.
- Technological advancements in diagnosis and treatment of AMD: There has been a significant advancement in technology when it comes to diagnosing and treating AMD, which is aiding in the growth of the market.
- Growing demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due to their lesser side effects as compared to traditional surgeries, thereby driving the growth of this market segment .
Scope Of The Report
Report Attributes
Report Details
Report Title
Age-related Macular Degeneration Market Research Report
By Type
Wet AMD, Dry AMD
By Application
Drugstore, Hospital, Others
By Companies
Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb, Gilead Sciences, Iconic Therapeutics, Neurotech Pharmaceuticals, Ohr Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Age-related Macular Degeneration Market Report Segments:
The global Age-related Macular Degeneration market is segmented on the basis of:
Types
Wet AMD, Dry AMD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drugstore, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer HealthCare
- F. Hoffmann-La Roche
- Novartis
- Regeneron Pharmaceuticals
- Alcon
- Allergan
- Avalanche
- Bausch+Lomb
- Gilead Sciences
- Iconic Therapeutics
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
Highlights of The Age-related Macular Degeneration Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wet AMD
- Dry AMD
- By Application:
- Drugstore
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Age-related Macular Degeneration Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Age-related macular degeneration (AMD) is a condition that affects the central vision, usually in people over 50. AMD can cause gradual loss of central vision, which may eventually lead to blindness.
Some of the key players operating in the age-related macular degeneration market are Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb, Gilead Sciences, Iconic Therapeutics, Neurotech Pharmaceuticals, Ohr Pharmaceutical.
The age-related macular degeneration market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Age-related Macular Degeneration Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Age-related Macular Degeneration Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Age-related Macular Degeneration Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Age-related Macular Degeneration Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Age-related Macular Degeneration Market Size & Forecast, 2018-2028
4.5.1 Age-related Macular Degeneration Market Size and Y-o-Y Growth
4.5.2 Age-related Macular Degeneration Market Absolute $ Opportunity
Chapter 5 Global Age-related Macular Degeneration Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Age-related Macular Degeneration Market Size Forecast by Type
5.2.1 Wet AMD
5.2.2 Dry AMD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Age-related Macular Degeneration Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Age-related Macular Degeneration Market Size Forecast by Applications
6.2.1 Drugstore
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Age-related Macular Degeneration Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Age-related Macular Degeneration Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Age-related Macular Degeneration Analysis and Forecast
9.1 Introduction
9.2 North America Age-related Macular Degeneration Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Age-related Macular Degeneration Market Size Forecast by Type
9.6.1 Wet AMD
9.6.2 Dry AMD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Age-related Macular Degeneration Market Size Forecast by Applications
9.10.1 Drugstore
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Age-related Macular Degeneration Analysis and Forecast
10.1 Introduction
10.2 Europe Age-related Macular Degeneration Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Age-related Macular Degeneration Market Size Forecast by Type
10.6.1 Wet AMD
10.6.2 Dry AMD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Age-related Macular Degeneration Market Size Forecast by Applications
10.10.1 Drugstore
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Age-related Macular Degeneration Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Age-related Macular Degeneration Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Age-related Macular Degeneration Market Size Forecast by Type
11.6.1 Wet AMD
11.6.2 Dry AMD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Age-related Macular Degeneration Market Size Forecast by Applications
11.10.1 Drugstore
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Age-related Macular Degeneration Analysis and Forecast
12.1 Introduction
12.2 Latin America Age-related Macular Degeneration Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Age-related Macular Degeneration Market Size Forecast by Type
12.6.1 Wet AMD
12.6.2 Dry AMD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Age-related Macular Degeneration Market Size Forecast by Applications
12.10.1 Drugstore
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Age-related Macular Degeneration Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Age-related Macular Degeneration Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Age-related Macular Degeneration Market Size Forecast by Type
13.6.1 Wet AMD
13.6.2 Dry AMD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Age-related Macular Degeneration Market Size Forecast by Applications
13.10.1 Drugstore
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Age-related Macular Degeneration Market: Competitive Dashboard
14.2 Global Age-related Macular Degeneration Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer HealthCare
14.3.2 F. Hoffmann-La Roche
14.3.3 Novartis
14.3.4 Regeneron Pharmaceuticals
14.3.5 Alcon
14.3.6 Allergan
14.3.7 Avalanche
14.3.8 Bausch+Lomb
14.3.9 Gilead Sciences
14.3.10 Iconic Therapeutics
14.3.11 Neurotech Pharmaceuticals
14.3.12 Ohr Pharmaceutical
